| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Profit before tax | -32.4 | -26.0 |
| Net income | -32.4 | -26.0 |
| EPS (diluted, $ a share) | $-0.27 | $-0.35 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, NYSE: CATX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Perspective Therapeutics, Inc.: key numbers
- Share price
- $0.9238Close, Nov 16
- Market cap
- $112M
- Shares outstanding
- 120.76MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Perspective Therapeutics, Inc.
All →Perspective Therapeutics Director Frank Morich Buys $14K of Stock
Frank Morich, Director, bought 15,000 shares of Perspective Therapeutics, Inc. at $0.9364 a share, worth $14K in total on Nov 16, 2026. Shares held after the trade: 30,000 (+100.0%).
- Value
- $14K
- Shares
- 15,000
- Price
- $0.9364
- Role
- Director
- Holding change
- +100.0%
- Trade date
- Nov 16, 2026
Perspective Therapeutics Director Robert F. Williamson III Buys $15.6K of Stock
Robert F. Williamson III, Director, bought 18,609 shares of Perspective Therapeutics, Inc. at $0.84 a share, worth $15.6K in total on Nov 12, 2026. Shares held after the trade: 28,473 (+188.7%).
- Value
- $15.6K
- Shares
- 18,609
- Price
- $0.8400
- Role
- Director
- Holding change
- +188.7%
- Trade date
- Nov 12, 2026
Perspective Therapeutics Director Frank Morich Buys $15K of Stock
Frank Morich, Director, bought 15,000 shares of Perspective Therapeutics, Inc. at $0.9971 a share, worth $15K in total on Nov 12, 2026. Shares held after the trade: 15,000.
- Value
- $15K
- Shares
- 15,000
- Price
- $0.9971
- Role
- Director
- Trade date
- Nov 12, 2026
Perspective Therapeutics Director Lori A. Woods Buys $20K of Stock
Lori A. Woods, Director, bought 23,750 shares of Perspective Therapeutics, Inc. at $0.8438 a share, worth $20K in total on Nov 12, 2026. Shares held after the trade: 28,557 (+494.1%).
- Value
- $20K
- Shares
- 23,750
- Price
- $0.8438
- Role
- Director
- Holding change
- +494.1%
- Trade date
- Nov 12, 2026
Perspective Therapeutics CMO Markus Puhlmann Buys $29.6K of Stock
Markus Puhlmann, CMO, bought 35,000 shares of Perspective Therapeutics, Inc. at $0.8447 a share, worth $29.6K in total on Nov 12, 2026. Shares held after the trade: 178,542 (+24.4%).
- Value
- $29.6K
- Shares
- 35,000
- Price
- $0.8447
- Role
- CMO
- Holding change
- +24.4%
- Trade date
- Nov 12, 2026
Perspective Therapeutics CEO Johan M. Spoor Buys $37.9K of Stock
Johan M. Spoor, CEO, bought 47,000 shares of Perspective Therapeutics, Inc. at $0.8073 a share, worth $37.9K in total on Nov 11, 2026. Shares held after the trade: 106,383 (+79.1%).
- Value
- $37.9K
- Shares
- 47,000
- Price
- $0.8073
- Role
- CEO
- Holding change
- +79.1%
- Trade date
- Nov 11, 2026